Get started
Author

Naremaddepalli S. Sudarshan

Observed names: N S Sudarshan, N. S. Sudarshan, N. Sudarshan, N.S. Sudarshan, Naremaddepalli S Sudarshan, Naremaddepalli Sudarshan, Sudarshan Naremaddepalli, Sudarshan S. Naremaddepalli
OpenAlex ID: A5089283691
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
2021 · Pottayil G. Sasikumar, Naremaddepalli S. Sudarshan, et al. · Communications Biology · 170
PDF
An Efficient Conversion of the Carboxylic Group ofN-Fmoc α-Amino Acids/Peptide Acids intoN-Formamides Employing Isocyanates as Key Intermediates
2007 · N. S. Sudarshan, N. Narendra, et al. · The Journal of Organic Chemistry · 20
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
2016 · Casey Ager, Matthew Reilley, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Abstract 4861: Oral immune checkpoint antagonists targeting PD-L1/VISTA or PD-L1/Tim3 for cancer therapy
2016 · Pottayil Sasikumar, N S Sudarshan, et al. · Cancer Research · 13
Abstract B006: Functional antagonism of VSIG8-mediated immune suppression by oral VISTA agents
2018 · Pottayil G. Sasikumar, Sudarshan S. Naremaddepalli, et al. · Molecular Cancer Therapeutics · 11
Abstract A36: CA-170, an oral small molecule PD-L1 and VISTA immune checkpoint antagonist, promotes T cell immune activation and inhibits tumor growth in pre-clinical models of cancer
2017 · Adam S. Lazorchak, Troy Patterson, et al. · Cancer Immunology Research · 11
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
2016 · Andreas Lundqvist, Vincent van Hoef, et al. · Journal for ImmunoTherapy of Cancer · 11
PDF
Synthesis of Ureidopeptides and Peptidyl Ureas Employing Bsmoc Chemistry
2007 · Vommina V. Suresh Babu, N. S. Sudarshan, et al. · International Journal of Peptide Research and Therapeutics · 7
Pre-clinical efficacy in multiple syngeneic models with oral immune checkpoint antagonists targeting PD-L1 and TIM-3
2016 · P. Sasikumar, N. Sudarshan, et al. · European Journal of Cancer · 6
Synthesis of 4-Amino-Thiazole Analogs of Fmoc-Amino Acids and Thiazole Linked N-Orthogonally Protected Dipeptidomimetics
2009 · N. Narendra, T. Vishwanatha, et al. · Protein and Peptide Letters · 6
Efficient Synthesis ofO-Succinimidyl-(tert-Butoxycarbonylamino)methyl Carbamates Derived from α-Amino Acids Accelerated by Ultrasound: Application to the Synthesis of Ureidodipeptides
2008 · Vommina V. Sureshbabu, Naremaddepalli S. Sudarshan, et al. · Synthetic Communications · 6
Peptidyl Carbamates: Efficient Synthesis Using N-Fmoc-β-aminoalkoxy Carbonyl Chlorides/Active Pentachlorophenyl Carbonates as Monomeric Building Blocks
2008 · Vommina V. Sureshbabu, N. S. Sudarshan, et al. · International Journal of Peptide Research and Therapeutics · 6
Abstract 4148: An orally bioavailable small molecule antagonist of TIM-3 signaling pathway shows potent anti-tumor activity
2019 · Pottayil G. Sasikumar, Sudarshan S. Naremaddepalli, et al. · Cancer Research · 3
Abstract B007: Potent antitumor activity of a novel and orally available small-molecule antagonist targeting the CD47/SIRPα pathway
2018 · Pottayil G. Sasikumar, Chennakrishnareddy Gundala, et al. · Molecular Cancer Therapeutics · 3
HOBt·DCHA-Mediated Synthesis of Sterically Hindered Peptides employing Fmoc-Amino Acid Chlorides in Both Solution-Phase and Solid Phase Methods
2008 · Vommina V. Sureshbabu, Naremaddepalli S. Sudarshan, et al. · Synthetic Communications · 3
Synthesis of N-urethane Protected β-Amino Alcohols Employing N -(protected-α-aminoacyl)benzotriazoles
2007 · Vommina V. Sureshbabu, N.S. Sudarshan, et al. · Journal of Chemical Research · 3
Abstract 3500: AUR103 an oral small molecule CD47 antagonist in combination with azacytidine and bortezomib exhibits potent anti-tumor activity in myeloma and leukemia models in vitro and in vivo
2022 · Girish C. Daginakatte, Sasikumar Pottayil, et al. · Cancer Research · 2
Simple and rapid synthesis of N α - urethane protected β -amino alcohols and peptide alcohols employing HATU
2009 · Vommina V. Sureshbabu, Naremaddepalli S. Sudarshan, et al. · ePrints@Bangalore University (Bangalore University) · 2
Microwave Assisted Alcoholysis of Isocyanates Derived from Nα-[(9-fluorenylmethyl)oxy]carbonyl Amino Acids: Synthesis of N-Fmoc-N1-Z-/Boc-/Alloc-/Bsmoc-gem-diamines
2006 · Rao Venkataramanarao, Naremaddepalli S Sudarshan, et al. · International Journal of Peptide Research and Therapeutics · 2
Abstract 3852: Combination efficacy and safety profile of an orally bioavailable small molecule agent targeting CD47/SIRPα axis
2018 · Girish Daginakatte, Sasikumar Pottayil, et al. · Cancer Research · 1
Abstract 1650: Targeting CD47- SIRPα interaction by novel peptide-based antagonists
2017 · Pottayil G. Sasikumar, Chennakrishnareddy Gundala, et al. · Cancer Research · 1
Synthesis of Fmoc-protected β-amino alcohols and peptidyl alcohols from Fmoc-amino acid / peptide acid azides
2006 · Vommina V. Suresh Babu, Kantharaju, et al. · ePrints@Bangalore University (Bangalore University) · 1
Synthesis of Peptidyl Ureas Employing O-succinimidyl-(9H-fluoren-9- ylmethoxycarbonylamino)methylcarbamate Derivatives as Activated Monomers
2006 · Vommina Sureshbabu, Naremaddepalli Sudarshan, et al. · Protein and Peptide Letters · 1
Microwave accelerated high speed solution synthesis of peptides employing HATU/HOAt
2005 · Naremaddepalli S. Sudarshan, Vommina V. Suresh Babu · ePrints@Bangalore University (Bangalore University) · 1
Abstract 4148: An orally bioavailable small molecule antagonist of TIM-3 signaling pathway shows potent anti-tumor activity
2019 · Pottayil G. Sasikumar, Sudarshan S. Naremaddepalli, et al. · Clinical Research (Excluding Clinical Trials)
Works count: 31
Citation count: 307
H-index: 7
I10-index: 7
Year
Topic
Type